Document is current
Any future updates will be listed below
-
Authors
Tao, Huan
Huang, Jiansheng http://orcid.org/0000-0002-5600-1737
Yancey, Patricia G. http://orcid.org/0000-0002-1385-3366
Yermalitsky, Valery
Blakemore, John L.
Zhang, Youmin
Ding, Lei
Zagol-Ikapitte, Irene
Ye, Fei
Amarnath, Venkataraman
Boutaud, Olivier
Oates, John A.
Roberts, L. Jackson II
Davies, Sean S.
Linton, MacRae F. http://orcid.org/0000-0002-9277-0453
- License Information
-
More Information
Article History
Received: 20 December 2018
Accepted: 27 July 2020
First Online: 14 August 2020
Competing interests
: M.F.L., S.S.D., V.A., O.B., J.A.O., and L.J.R.II are inventors on a patent application for the use of 2-HOBA and related dicarbonyl scavengers for the treatment of cardiovascular disease. M.F.L. has received reseach funding from Amgen, Regeneron, Ionis, Merck, REGENXBIO, Sanofi and Novartis and has served as a consultant for Esperion, Alexion Pharmaceuticals and REGENXBIO. All the other authors (H.T., J.H., P.G.Y., J.L.B., F.Y., V.Y., V.Z., L.D., and I.Z.I.) declare no competing interests.
